vs
帕可Bio（PACB）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是帕可Bio的1.3倍（$57.1M vs $44.6M），REGIS CORP净利率更高（0.8% vs -90.4%，领先91.2%），REGIS CORP同比增速更快（22.3% vs 13.8%），REGIS CORP自由现金流更多（$891.0K vs $-19.9M），过去两年REGIS CORP的营收复合增速更高（7.8% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
PACB vs RGS — 直观对比
营收规模更大
RGS
是对方的1.3倍
$44.6M
营收增速更快
RGS
高出8.4%
13.8%
净利率更高
RGS
高出91.2%
-90.4%
自由现金流更多
RGS
多$20.8M
$-19.9M
两年增速更快
RGS
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $57.1M |
| 净利润 | $-40.4M | $456.0K |
| 毛利率 | 37.1% | — |
| 营业利润率 | -92.3% | 10.8% |
| 净利率 | -90.4% | 0.8% |
| 营收同比 | 13.8% | 22.3% |
| 净利润同比 | -1802.7% | -94.0% |
| 每股收益（稀释后） | $-0.11 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBRGS
| Q4 25 | $44.6M | $57.1M | ||
| Q3 25 | $38.4M | $59.0M | ||
| Q2 25 | $39.8M | $60.4M | ||
| Q1 25 | $37.2M | $57.0M | ||
| Q4 24 | $39.2M | $46.7M | ||
| Q3 24 | $40.0M | $46.1M | ||
| Q2 24 | $36.0M | $49.4M | ||
| Q1 24 | $38.8M | $49.2M |
净利润PACBRGS
| Q4 25 | $-40.4M | $456.0K | ||
| Q3 25 | $-38.0M | $1.4M | ||
| Q2 25 | $-41.9M | $116.5M | ||
| Q1 25 | $-426.1M | $250.0K | ||
| Q4 24 | $2.4M | $7.6M | ||
| Q3 24 | $-60.7M | $-853.0K | ||
| Q2 24 | $-173.3M | $91.2M | ||
| Q1 24 | $-78.2M | $-2.3M |
毛利率PACBRGS
| Q4 25 | 37.1% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 29.1% | — |
营业利润率PACBRGS
| Q4 25 | -92.3% | 10.8% | ||
| Q3 25 | -101.1% | 10.0% | ||
| Q2 25 | -112.8% | 12.1% | ||
| Q1 25 | -1154.5% | 8.8% | ||
| Q4 24 | -390.1% | 11.8% | ||
| Q3 24 | -160.3% | 4.6% | ||
| Q2 24 | -488.3% | — | ||
| Q1 24 | -209.6% | 8.3% |
净利率PACBRGS
| Q4 25 | -90.4% | 0.8% | ||
| Q3 25 | -98.9% | 2.3% | ||
| Q2 25 | -105.4% | 192.9% | ||
| Q1 25 | -1146.8% | 0.4% | ||
| Q4 24 | 6.0% | 16.4% | ||
| Q3 24 | -151.9% | -1.9% | ||
| Q2 24 | -481.3% | 184.7% | ||
| Q1 24 | -201.4% | -4.7% |
每股收益（稀释后）PACBRGS
| Q4 25 | $-0.11 | $0.16 | ||
| Q3 25 | $-0.13 | $0.49 | ||
| Q2 25 | $-0.14 | $43.67 | ||
| Q1 25 | $-1.44 | $0.08 | ||
| Q4 24 | $-0.44 | $2.71 | ||
| Q3 24 | $-0.22 | $-0.36 | ||
| Q2 24 | $-0.64 | $38.40 | ||
| Q1 24 | $-0.29 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $5.3M | $188.7M |
| 总资产 | $784.1M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资PACBRGS
| Q4 25 | $279.5M | $18.4M | ||
| Q3 25 | $298.7M | $16.6M | ||
| Q2 25 | $314.7M | $17.0M | ||
| Q1 25 | $343.1M | $13.3M | ||
| Q4 24 | $389.9M | $10.2M | ||
| Q3 24 | $471.1M | $6.3M | ||
| Q2 24 | $509.8M | $10.1M | ||
| Q1 24 | $561.9M | $5.9M |
总债务PACBRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益PACBRGS
| Q4 25 | $5.3M | $188.7M | ||
| Q3 25 | $36.1M | $187.6M | ||
| Q2 25 | $61.5M | $185.6M | ||
| Q1 25 | $91.6M | $68.6M | ||
| Q4 24 | $506.6M | $66.7M | ||
| Q3 24 | $453.1M | $56.4M | ||
| Q2 24 | $492.7M | $56.8M | ||
| Q1 24 | $649.0M | $-35.8M |
总资产PACBRGS
| Q4 25 | $784.1M | $588.3M | ||
| Q3 25 | $803.2M | $592.1M | ||
| Q2 25 | $825.5M | $599.0M | ||
| Q1 25 | $860.8M | $511.2M | ||
| Q4 24 | $1.3B | $530.1M | ||
| Q3 24 | $1.5B | $508.9M | ||
| Q2 24 | $1.5B | $530.5M | ||
| Q1 24 | $1.7B | $543.7M |
负债/权益比PACBRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $891.0K |
| 自由现金流率自由现金流/营收 | -44.6% | 1.6% |
| 资本支出强度资本支出/营收 | 1.9% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $14.9M |
8季度趋势，按日历期对齐
经营现金流PACBRGS
| Q4 25 | $-19.1M | $1.7M | ||
| Q3 25 | $-18.7M | $2.3M | ||
| Q2 25 | $-29.4M | $6.8M | ||
| Q1 25 | $-44.1M | $6.2M | ||
| Q4 24 | $-30.6M | $2.1M | ||
| Q3 24 | $-45.5M | $-1.3M | ||
| Q2 24 | $-54.3M | $5.1M | ||
| Q1 24 | $-75.7M | $-277.0K |
自由现金流PACBRGS
| Q4 25 | $-19.9M | $891.0K | ||
| Q3 25 | $-18.8M | $1.9M | ||
| Q2 25 | $-29.9M | $6.2M | ||
| Q1 25 | $-45.4M | $5.9M | ||
| Q4 24 | $-32.3M | $1.7M | ||
| Q3 24 | $-46.3M | $-1.4M | ||
| Q2 24 | $-55.7M | $5.1M | ||
| Q1 24 | $-79.6M | $-326.0K |
自由现金流率PACBRGS
| Q4 25 | -44.6% | 1.6% | ||
| Q3 25 | -48.9% | 3.2% | ||
| Q2 25 | -75.3% | 10.3% | ||
| Q1 25 | -122.3% | 10.3% | ||
| Q4 24 | -82.3% | 3.6% | ||
| Q3 24 | -115.7% | -3.0% | ||
| Q2 24 | -154.8% | 10.3% | ||
| Q1 24 | -205.0% | -0.7% |
资本支出强度PACBRGS
| Q4 25 | 1.9% | 1.4% | ||
| Q3 25 | 0.2% | 0.7% | ||
| Q2 25 | 1.4% | 0.9% | ||
| Q1 25 | 3.7% | 0.6% | ||
| Q4 24 | 4.1% | 0.9% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 4.1% | 0.0% | ||
| Q1 24 | 10.0% | 0.1% |
现金转化率PACBRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | -12.93× | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
